Effects of the microbial secondary metabolites pyrrolnitrin, phenazine and patulin on INS-1 rat pancreatic β-cells

Abstract The effects on pancreatic β-cell viability and function of three microbial secondary metabolites pyrrolnitrin, phenazine and patulin were investigated, using the rat clonal pancreatic β-cell line, INS-1. Cells were exposed to 10-fold serial dilutions (range 0–10 µg mL−1) of the purified com...

Full description

Saved in:
Bibliographic Details
Published inFEMS immunology and medical microbiology Vol. 63; no. 2; pp. 217 - 227
Main Authors Nisr, Raid B., Russell, Mark A., Chrachri, Abdesslam, Moody, A. John, Gilpin, Martyn L.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.11.2011
Blackwell
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract The effects on pancreatic β-cell viability and function of three microbial secondary metabolites pyrrolnitrin, phenazine and patulin were investigated, using the rat clonal pancreatic β-cell line, INS-1. Cells were exposed to 10-fold serial dilutions (range 0–10 µg mL−1) of the purified compounds for 2, 24 and 72 h. After 2 h exposure, only patulin (10 µg mL−1) was cytotoxic. All compounds showed significant cytotoxicity after 24 h. None of the compounds altered insulin secretion with 2 and 20 mM glucose after 2 h. However, after 24 h treatment, phenazine and pyrrolnitrin (10 and 100 ng mL−1) potentiated insulin production and glucose-stimulated insulin secretion, whereas patulin had no effect. Exposure (24 h) to either phenazine (100 ng mL−1) or pyrrolnitrin (10 ng mL−1) caused similar increases in the Ca2+ content of INS-1 cells. The outward membrane current was inhibited after 24 h exposure to either phenazine (100 ng mL−1) or pyrrolnitrin (10 or 100 ng mL−1). This study presents novel data suggesting that high concentrations of pyrrolnitrin and phenazine are cytotoxic to pancreatic β-cells and thus possibly diabetogenic, whereas at lower concentrations these agents are nontoxic and may be insulinotropic. The possible role of such agents in the development of cystic fibrosis-related diabetes is discussed.
ISSN:0928-8244
1574-695X
2049-632X
DOI:10.1111/j.1574-695X.2011.00844.x